5027 A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and non-steroidal (anastrozole) aromatase inhibitors on biomarkers in post-menopausal women with hormone receptor positive locally advanced breast cancer (LABC)

✍ Scribed by O. Freedman; E. Amir; G. Dranitsaris; M. Dowsett; D.E.C. Cole; W. Hanna; F. O'Malley; E. Folkerd; S. Verma; M.J. Clemons

• Book ID: 119600677
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 49 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)70919-x